MicroRNA-34c-3p is an early predictive biomarker for doxorubicin-induced glomerular injury progression in male Sprague-Dawley rats

Toxicology Research

Volumn 3, Issue 5, 2014, Pages 384-394

  Church, Rachel J ^a   McDuffie, J Eric ^b   Sonee, Manisha ^b   Otieno, Monicah ^b   Ma, Jing Ying ^b   Liu, Xuejun ^b   Watkins, Paul B ^a   Harrill, Alison H ^a  

^a Hamner UNC Institute for Drug Safety Sciences   (United States)

^b JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BETA 2 MICROGLOBULIN; CREATININE; CYSTATIN C; DOXORUBICIN; KIDNEY INJURY MOLECULE 1; MICRORNA; MICRORNA 34C 3P; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; OSTEOPONTIN; PROTEIN; UNCLASSIFIED DRUG;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE COURSE; HISTOPATHOLOGY; MALE; NEPHROTOXICITY; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; RAT; SPRAGUE DAWLEY RAT; UREA NITROGEN BLOOD LEVEL;

EID: 84905712149     PISSN: 2045452X     EISSN: 20454538     Source Type: Journal    
DOI: 10.1039/c4tx00051j     Document Type: Article

References (43)

1. J. L. Robertson Chemically induced glomerular injury: a review of basic mechanisms and specific xenobiotics Toxicol. Pathol. 1998 26 64 72 (Pubitemid 28100691)
2. H. Y. Tiong P. Huang S. Xiong Y. Li A. Vathsala D. Zink Drug-Induced Nephrotoxicity: Clinical Impact and Preclinical in Vitro Models Mol. Pharmaceutics 2014 11 1933 1948
3. S. M. Moran B. D. Myers Course of acute renal failure studied by a model of creatinine kinetics Kidney Int. 1985 27 928 937 (Pubitemid 15035559)
4. V. S. Vaidya J. S. Ozer F. Dieterle F. B. Collings V. Ramirez S. Troth N. Muniappa et al., Kidney Injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies Nat. Biotechnol. 2010 28 478 485
5. C. C. Szeto K. M. Chow Nephrotoxicity related to new therapeutic compounds Ren. Fail. 2005 27 329 333 (Pubitemid 40770613)
6. F. Dieterle F. Sistare F. Goodsaid M. Papaluca J. S. Ozer C. P. Webb W. Baer et al., Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium Nat. Biotechnol. 2010 28 455 462
7. K. Vlasakova Z. Erdos S. P. Troth K. McNulty V. Chapeau-Campredon N. Mokrzycki N. Muniappa et al., Evaluation of the relative performance of 12 urinary biomarkers for renal safety across 22 rat sensitivity and specificity studies Toxicol. Sci. 2014 138 3 20
8. D. P. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 2004 116 281 297
9. J. A. Weber D. H. Baxter S. Zhang D. Y. Huang K. H. Huang M. J. Lee D. J. Galas et al., The microRNA spectrum in 12 body fluids Clin. Chem. 2010 56 1733 1741
10. P. S. Mitchell R. K. Parkin E. M. Kroh B. R. Fritz S. K. Wyman E. L. Pogosova-Agadjanyan A. Peterson et al., Circulating microRNAs as stable blood-based markers for cancer detection Proc. Natl. Acad. Sci. U. S. A. 2008 105 10513 10518
11. C. Mall D. M. Rocke B. Durbin-Johnson R. H. Weiss Stability of miRNA in human urine supports its biomarker potential Biomarkers Med. 2013 7 623 631
12. J. Lu G. Getz E. A. Miska E. Alvarez-Saavedra J. Lamb D. Peck A. Sweet-Cordero et al., MicroRNA expression profiles classify human cancers Nature 2005 435 834 838 (Pubitemid 40839735)
13. Y. Sun S. Koo N. White E. Peralta C. Esau N. M. Dean R. J. Perera Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs Nucleic Acids Res. 2004 32 e188
14. Z. Tian A. S. Greene J. L. Pietrusz I. R. Matus M. Liang MicroRNA-target pairs in the rat kidney identified by microRNA microarray, proteomic, and bioinformatic analysis Genome Res. 2008 18 404 411 (Pubitemid 351347083)
15. P. J. Starkey Lewis J. Dear V. Platt K. J. Simpson D. G. Craig D. J. Antoine N. S. French et al., Circulating microRNAs as potential markers of human drug-induced liver injury Hepatology 2011 54 1767 1776
16. K. Wang S. Zhang B. Marzolf P. Troisch A. Brightman Z. Hu L. E. Hood et al., Circulating microRNAs, potential biomarkers for drug-induced liver injury Proc. Natl. Acad. Sci. U. S. A. 2009 106 4402 4407
17. K. Ramachandran J. Saikumar V. Bijol J. L. Koyner J. Qian R. A. Betensky S. S. Waikar et al., Human miRNome profiling identifies microRNAs differentially present in the urine after kidney injury Clin. Chem. 2013 59 1742 1752
18. J. C. Gautier B. Riefke J. Walter P. Kurth L. Mylecraine V. Guilpin N. Barlow et al., Evaluation of novel biomarkers of nephrotoxicity in two strains of rat treated with Cisplatin Toxicol. Pathol. 2010 38 943 956
19. E. M. Kroh R. K. Parkin P. S. Mitchell M. Tewari Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR) Methods 2010 50 298 301
20. M. Doleshal A. A. Magotra B. Choudhury B. D. Cannon E. Labourier A. E. Szafranska Evaluation and validation of total RNA extraction methods for microRNA expression analyses in formalin-fixed, paraffin-embedded tissues J. Mol. Diagn. 2008 10 203 211 (Pubitemid 351692162)
21. E. Harpur D. Ennulat D. Hoffman G. Betton J. C. Gautier B. Riefke D. Bounous et al., Biological qualification of biomarkers of chemical-induced renal toxicity in two strains of male rat Toxicol. Sci. 2011 122 235 252
22. J. C. Gautier T. Gury M. Guffroy R. Khan-Malek D. Hoffman S. Pettit E. Harpur Normal Ranges and Variability of Novel Urinary Renal Biomarkers in Sprague-Dawley Rats: Comparison of Constitutive Values between Males and Females and across Assay Platforms Toxicol. Pathol. 2014 10.1177/0192623313520352
23. A. theridge I. Lee L. Hood D. Galas K. Wang Extracellular microRNA: a new source of biomarkers Mutat. Res. 2011 717 85 90
24. J. A. Jefferson S. J. Shankland R. H. Pichler Proteinuria in diabetic kidney disease: a mechanistic viewpoint Kidney Int. 2008 74 22 36 (Pubitemid 351841893)
25. T. Ichimura C. C. Hung S. A. Yang J. L. Stevens J. V. Bonventre Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury Am. J. Physiol. Renal Physiol. 2004 286 F552 F563
26. R. Cianciolo L. Yoon D. Krull A. Stokes A. Rodriguez H. Jordan D. Cooper et al., Gene expression analysis and urinary biomarker assays reveal activation of tubulointerstitial injury pathways in a rodent model of chronic proteinuria (Doxorubicin nephropathy) Nephron Exp. Nephrol. 2013 124 1 10
27. J. Lorenzen R. Shah A. Biser S. A. Staicu T. Niranjan A. M. Garcia A. Gruenwald et al., The role of osteopontin in the development of albuminuria J. Am. Soc. Nephrol. 2008 19 884 890
28. H. Y. Lan X. Q. Yu N. Yang D. J. Nikolic-Paterson W. Mu R. Pichler R. J. Johnson et al., De novo glomerular osteopontin expression in rat crescentic glomerulonephritis Kidney Int. 1998 53 136 145 (Pubitemid 28066913)
29. T. Umekawa K. Kohri T. Kurita S. Hirota S. Nomura Y. Kitamura Expression of osteopontin messenger RNA in the rat kidney on experimental model of renal stone Biochem. Mol. Biol. Int. 1995 35 223 230
30. T. Bertani A. Poggi R. Pozzoni F. Delaini G. Sacchi Y. Thoua G. Mecca et al., Adriamycin-induced nephrotic syndrome in rats: sequence of pathologic events Lab. Invest. 1982 46 16 23 (Pubitemid 12167012)
31. C. Vacchi-Suzzi Y. Bauer B. R. Berridge S. Bongiovanni K. Gerrish H. K. Hamadeh M. Letzkus et al., Perturbation of microRNAs in rat heart during chronic doxorubicin treatment PLoS One 2012 7 e40395
32. X. Yang J. Greenhaw Q. Shi Z. Su F. Qian K. Davis D. L. Mendrick et al., Identification of urinary microRNA profiles in rats that may diagnose hepatotoxicity Toxicol. Sci. 2012 125 335 344
33. M. Mazer J. Perrone Acetaminophen-induced nephrotoxicity: pathophysiology, clinical manifestations, and management J. Med. Toxicol. 2008 4 2 6
34. F. Ozturk M. Ucar I. C. Ozturk N. Vardi K. Batcioglu Carbon tetrachloride-induced nephrotoxicity and protective effect of betaine in Sprague-Dawley rats Urology 2003 62 353 356 (Pubitemid 36952105)
35. L. Kuritzky R. Toto P. Van Buren Identification and management of albuminuria in the primary care setting J. Clin. Hypertens. 2011 13 438 449
36. H. Dweep C. Sticht P. Pandey N. Gretz miRWalk-database: prediction of possible miRNA binding sites by "walking" the genes of three genomes J. Biomed. Inform. 2011 44 839 847
37. D. M. Sadlier X. Ouyang B. McMahon W. Mu R. Ohashi K. Rodgers D. Murray et al., Microarray and bioinformatic detection of novel and established genes expressed in experimental anti-Thy1 nephritis Kidney Int. 2005 68 2542 2561 (Pubitemid 43251000)
38. R. E. Gilbert D. J. Kelly T. McKay S. Chadban P. A. Hill M. E. Cooper R. C. Atkins et al., PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis Kidney Int. 2001 59 1324 1332 (Pubitemid 32281220)
39. P. Soriano Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice Genes Dev. 1994 8 1888 1896
40. G. Ghosh Choudhury Y. S. Kim M. Simon J. Wozney S. Harris N. Ghosh-Choudhury H. E. Abboud Bone morphogenetic protein 2 inhibits platelet-derived growth factor-induced c-fos gene transcription and DNA synthesis in mesangial cells. Involvement of mitogen-activated protein kinase J. Biol. Chem. 1999 274 10897 10902
41. A. Cohen-Bucay G. Viswanathan Urinary markers of glomerular injury in diabetic nephropathy Int. J. Nephrol. 2012 2012 146987
42. A. Togawa T. Yamamoto H. Suzuki H. Fukasawa N. Ohashi Y. Fujigaki K. Kitagawa et al., Ubiquitin-dependent degradation of Smad2 is increased in the glomeruli of rats with anti-thymocyte serum nephritis Am. J. Pathol. 2003 163 1645 1652 (Pubitemid 37175111)
43. C. Wei C. C. Moller M. M. Altintas J. Li K. Schwarz S. Zacchigna L. Xie et al., Modification of kidney barrier function by the urokinase receptor Nat. Med. 2008 14 55 63